In OVCAR-3 ovarian cancer cells, it was demonstrated that RES blocked protein kinase B/glycogen synthase kinase (AKT/GSK) and ERK activation, resulting in suppression of cell proliferation [48]. This evidence concerns the gene AKT1 and ovarian carcinoma.